🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

Recruitingn/aAges 18 Years - 65 YearsAllIzmir Democracy University
NCT07497360 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Peripheral artery disease (PAD) is a chronic and progressive condition caused by narrowing or blockage of arteries in the lower limbs due to atherosclerosis. It primarily affects adults over 50, with prevalence increasing with age, and its clinical presentation ranges from asymptomatic cases to severe ischemia that may require amputation. Intermittent claudication, characterized by exercise-induced leg pain that resolves with rest, is the most common early symptom. Impaired blood flow, poor vascularization, and muscle loss contribute to reduced lower limb strength and functional capacity, which are associated with higher morbidity and mortality. Walking exercises is a cornerstone of PAD management, particularly for patients with no or mild symptoms, making the assessment of lower limb strength and mobility essential for designing rehabilitation programs. The 30-second sit-to-stand test

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged between 18 and 65 years * Diagnosed with peripheral artery disease, Fontaine stage I-II, confirmed by peripheral angiography or Doppler ultrasonography * Willingness to participate in the study * Access to a smartphone and the internet Exclusion Criteria: * Presence of orthopedic, neurological, or psychological conditions that limit physical activity * Neurological or musculoskeletal disorders affecting standing or walking * History of ischemic amputation * Acute inflammatory condition * Use of walking aids * Visual or hearing impairment * Vestibular system disorder * Cognitive impairment affecting cooperation * Severe cardiopulmonary diseases limiting walking ability * Major surgery or myocardial infarction within the last three months * Unstable coronary artery disease
💊

What it tests

  • Not listed
📍

Where

1 site
Dokuz Eylul University Faculty of Medicine
Izmir, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy